← Back to Screener
Hims & Hers Health, Inc. (HIMS)
Price$26.19
Value ScoreF
Growth ScoreC
Momentum ScoreC
Favorite Metrics
Price vs S&P 500 (26W)-42.05%
Price vs S&P 500 (4W)-7.35%
VGM Score39.85
Market Capitalization$6.06B
P/E Ratio (Annual)47.22x
All Metrics
P/CF (Annual)20.21x
Book Value / Share (Quarterly)$1.93
P/TBV (Annual)21.44x
Revenue Growth (3Y)64.55%
Cash Flow / Share (Quarterly)$0.26
Price vs S&P 500 (YTD)-27.50%
Gross Margin (TTM)72.92%
Net Profit Margin (TTM)-0.56%
EPS (TTM)$-0.10
10-Day Avg Trading Volume17.99M
EPS Excl Extra (TTM)$-0.10
EPS (Annual)$0.50
ROI (Annual)8.48%
Gross Margin (Annual)73.84%
Net Profit Margin (5Y Avg)-8.15%
Cash / Share (Quarterly)$3.25
P/E Basic Excl Extra (TTM)42.63x
Revenue Growth QoQ (YoY)3.77%
EPS Growth (5Y)63.46%
P/E Normalized (Annual)47.22x
ROA (Last FY)5.96%
Revenue Growth TTM (YoY)32.81%
EBITD / Share (TTM)$0.15
ROE (5Y Avg)-1.98%
Operating Margin (TTM)-1.29%
Cash Flow / Share (Annual)$0.25
P/B Ratio13.59x
P/B Ratio (Quarterly)10.61x
Net Income / Employee (Annual)$52,600
EV / Revenue (TTM)2.88x
ROA (TTM)-0.62%
EPS Growth QoQ (YoY)-26.29%
EV / EBITDA (TTM)181.35x
EPS Incl Extra (Annual)$0.50
Current Ratio (Annual)1.90x
Quick Ratio (Quarterly)1.48x
3-Month Avg Trading Volume34.06M
52-Week Price Return-50.37%
EV / Free Cash Flow (Annual)118.67x
P/E Incl Extra (TTM)42.63x
Revenue / Employee (TTM)$970,400
Tangible BV / Share (Quarterly)$0.80
P/S Ratio (Annual)2.58x
Asset Turnover (Annual)1.09x
52-Week High$70.43
Operating Margin (5Y Avg)-10.02%
EPS Excl Extra (Annual)$0.50
26-Week Price Return-34.13%
Quick Ratio (Annual)1.61x
13-Week Price Return64.92%
Total Debt / Equity (Annual)1.80x
Current Ratio (Quarterly)1.69x
Enterprise Value$6.81B
Asset Turnover (TTM)1.11x
Book Value / Share Growth (5Y)-20.91%
Revenue / Employee (Annual)$961,400
Inventory Turnover (Annual)8.50x
Pretax Margin (Annual)5.28%
Cash / Share (Annual)$2.54
3-Month Return Std Dev119.30%
Gross Margin (5Y Avg)77.61%
Net Income / Employee (TTM)$-5,400
ROE (Last FY)23.73%
EPS Basic Excl Extra (Annual)$0.50
P/FCF (TTM)45.79x
Receivables Turnover (TTM)30.27x
EV / Free Cash Flow (TTM)112.82x
Total Debt / Equity (Quarterly)2.18x
EPS Incl Extra (TTM)$-0.10
Receivables Turnover (Annual)122.82x
ROI (TTM)-0.88%
P/S Ratio (TTM)2.56x
Pretax Margin (5Y Avg)-9.11%
Revenue / Share (Annual)$9.09
Tangible BV / Share (Annual)$1.52
Forward P/E17667.40x
Price vs S&P 500 (52W)-74.74%
P/E Ratio (TTM)42.63x
EPS Growth TTM (YoY)-4.65%
Year-to-Date Return-19.34%
5-Day Price Return-5.66%
EPS Normalized (Annual)$0.50
ROA (5Y Avg)-5.02%
Net Profit Margin (Annual)5.47%
Month-to-Date Return0.15%
Cash Flow / Share (TTM)$-0.13
EBITD / Share (Annual)$0.62
Operating Margin (Annual)4.50%
LT Debt / Equity (Annual)1.80x
P/CF (TTM)21.63x
ROI (5Y Avg)-5.03%
P/E Excl Extra (TTM)42.63x
LT Debt / Equity (Quarterly)2.18x
EPS Basic Excl Extra (TTM)$-0.10
P/TBV (Quarterly)25.56x
P/B Ratio (Annual)13.66x
Inventory Turnover (TTM)8.27x
Pretax Margin (TTM)-1.61%
Book Value / Share (Annual)$2.38
Price vs S&P 500 (13W)56.67%
Beta2.45x
P/FCF (Annual)105.58x
Revenue / Share (TTM)$10.38
ROE (TTM)-2.48%
52-Week Low$13.74
vGradeF
gGradeC
mGradeC
vgmGradeD
Show chart for
Earnings Surprise History
Q1 26-0.19est. 0.04
Analyst Recommendations
Feb 2026
Mar 2026
Apr 2026
May 2026
3.36
2.71
3.50
3.52
Industry Peers — Physicians' Offices(10)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
HIMSHims & Hers Health, Inc. | F | C | C | $26.19 |
| TDOCTeladoc Health, Inc. | A | C | C | $7.05 |
| TOIThe Oncology Institute, Inc. Common Stock | D | A | A | $4.87 |
| AIRSAirSculpt Technologies, Inc. Common Stock | F | D | A | $5.11 |
| SBCSBC Medical Group Holdings Incorporated Common Stock | B | F | D | $3.01 |
| LFMDLifeMD, Inc. Common Stock | D | C | B | $4.89 |
| AUNAAuna S.A. | A | D | C | $4.41 |
| BMGLBasel Medical Group Ltd Ordinary Shares | B | B | F | $0.54 |
| CCMConcord Medical Services Holding Limited | B | B | C | $4.78 |
| SBCWWSBC Medical Group Holdings Incorporated Warrants | — | — | C | $0.17 |
| TOIIWThe Oncology Institute, Inc. Warrant | — | — | F | $0.05 |
About
Hims & Hers operates a U.S.-focused telehealth platform connecting patients with licensed healthcare professionals for treatments across sexual health, hair loss, hormone health, weight loss, dermatology, and mental health, supplemented by laboratory testing and wellness products. Prescriptions are fulfilled through licensed online pharmacies, generating revenue from prescription services, testing, and product sales. The mobile platform also provides educational content, community support, and wellness programs that drive patient engagement.